Fadi Salloum

Has grant

Professor of Medicine - Congdon Endowed Chair, VCU Pauley Heart Center

Virginia Commonwealth University Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Fadi Salloum is a Professor of Medicine and the Congdon Endowed Chair at the VCU Pauley Heart Center, part of Virginia Commonwealth University Medical Center. His research areas include cardiovascular health, cardio-oncology, and the effects of dietary quality on cardiac function, with recent publications addressing topics such as the impact of chemotherapy on cardiac performance and the role of immune activation in coronary artery disease outcomes. Dr. Salloum's work contributes significantly to the understanding of cardiovascular issues in cancer patients and the prioritization of basic and translational science in the field.

Recent Grants

Grant: Open

Impact of chronic psychosocial stress and the NLRP3 inflammasome on cardiovascular function following chemotherapy

Open Date: 2023-04-01

Close Date: 2027-03-31

Articles (17)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Ion S. Jovin

University of Virginia Health System

UNITED STATES

View details

Thomas E. Sharp III

Assistant Professor

University of South Florida

UNITED STATES

View details

John Calvert

Associate Professor

Emory University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fadi Salloum

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Remodeling Cardiovascular Research: Ready to Sacrifice Animal Models?

Hypertension Severity and Declines in Left Ventricular Ejection Fraction Among Women Receiving Adjuvant Chemotherapy for Breast Cancer (WF-97415 UPBEAT).

Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety

Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)

Reduced Thoracic Aortic Distensibility Upon Breast Cancer Diagnosis (WF-97415 and WF-98213)

NLRP3-mediated inflammation in cardio-oncology: sterile yet harmful

Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery Disease.

Priorities in Cardio-Oncology Basic and Translational Science

Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia.

Higher diet quality relates to better cardiac function in cancer survivors: The multi-ethnic study of atherosclerosis.

Physical Activity During Breast Cancer Therapy Associates With Preserved Exercise Capacity and Cardiac Function (WF97415).

Mitochondrial H 2 S Regulates BCAA Catabolism in Heart Failure

Melanoma Treatment

Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signaling.

Cardiac Gene Therapy With Relaxin Receptor 1 Overexpression Protects Against Acute Myocardial Infarction.

Sacubitril/Valsartan for the Prevention and Treatment of Postinfarction Heart Failure: Ready to Use?

Abnormal Lysosomal Positioning and Small Extracellular Vesicle Secretion in Arterial Stiffening and Calcification of Mice Lacking Mucolipin 1 Gene

Collaborators (3)

Ion S. Jovin

Thomas E. Sharp III

John Calvert

Make your next move.